PrintFriendly

Print Friendly, PDF & Email

NHF Innovative Investigator Award

*Application Deadline: Tuesday Nov 7, 2017
Award Start Date: January 2, 2018

 

The National Hemophilia Foundation (NHF), seeks research grant applications from health care providers within the hemophilia treatment center (HTC) network for innovative-investigator research (IIR) projects that demonstrate a commitment to the bleeding disorders community supporting NHF's goal to develop outcomes related data. Innovative projects that promote the development of novel technologies and/or therapies to advance the field of bleeding disorders research are especially encouraged.

Funding Amount: Up to $60,000 per grant. In 2017 up to two grants will be awarded. This funding is for a period of 12-18 months.

 

Eligibility Requirements

Candidates must be associated with a federally funded HTC. All healthcare providers are eligible. Interdisciplinary applications are encouraged and strongly supported.

United States citizenship is not required, but applicants must be affiliated with or be faculty members of a federally funded HTC. Only non-commercial institutions and investigators associated with a non-commercial institution are eligible to apply for this award.

The NHF's IIR grantee is expected to remain at their HTC (institution) for the duration of the project. Letters of support from appropriate officials (ex: candidate's HTC supervisor/leadership, department chair and institution's financial grants/contracts officer) indicating the institution’s commitment to allow the candidate to focus his/her efforts on the stated research project will be required.

 

Scope of Research

NHF is interested in funding innovative research studies in the area of bleeding disorders.  For additional detail on project scope, please review the RFA attached below. 

All IIR research proposals are subjected to a rigorous peer review process.  Applications will be reviewed on scientific merit and scored in terms of project significance, scientific approach, innovation, investigator qualifications and institutional environment. 

 

Deadlines

All interested candidates need to submit an application by no later than 11:59 pm EST on Tuesday, November 7, 2017. Application not time stamped by 11.59 pm EST on 11/7/2017  will not be accepted or considered. 

Applications will be evaluated by a select NHF Research Review Committee based upon the received applications. The Committee will make recommendations to NHF where the final decision will be determined.

Applications should be emailed to Michelle Witkop, DNP, FNP-BC, Head of Research, at mwitkop@hemophilia.orgOnly electronically submitted applications utilizing the official fillable pdf application will be accepted. All application must be accompanied by an NIH-style biosketch or CV.

AttachmentSize
PDF icon IIR Policies & Procedures105.25 KB